Skip to content

Effect of diluted autologous blood transfusion on body temperature and prognosis in patients during perioperative period

Effect of diluted autologous blood transfusion on body temperature and prognosis in patients during perioperative period

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014411
Enrollment
Unknown
Registered
2018-01-12
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preoperative hypothermia

Interventions

Control group:Null
Infusion heating group.:Blood transfusion infusion heating
Warm blanket heating group:Warm blanket heating
Blood transfusion infusion heating compound heating blanket group:Blood transfusion infusion heating compound heating blanket

Sponsors

Ningbo No.2 Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patient ASA I-II; 2. Patients undergoing elective noncardiac surgery under general anesthesia; 3. Predictors of intraoperative hemorrhage, preoperative assessment can be implemented diluted autologous blood transfusion, preoperative Hct (%)> 30 and Hb (g / dl)> 10; 4. Surgery time 2 - 4 hours; 5. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with central hyperthermia, including cerebrovascular disease, traumatic brain injury and brain surgery, epilepsy, central hyperthermia due to acute hydrocephalus, confirmed evidence of hypothyroidism and hyperthyroidism; 2. Abnormalities in thermoregulation include malignant hyperthermia (MHS) and neuroleptic malignant syndrome; 3. Infective fever or cold; 4. The patient's core body temperature =37.8C within 3 days before surgery; 5. Ear infections and other diseases affecting the ear drum temperature and the exact determination of the operation; 6. Intraoperative surgery to take the initiative to cool the measures.

Design outcomes

Primary

MeasureTime frame
Temperature:;

Countries

China

Contacts

Public ContactZheng Jinwei

Ningbo 2nd Hospital

75041051@qq.com+86 13777112140

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026